SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891293-18-000080
Filing Date
2018-08-03
Accepted
2018-08-02 18:07:07
Documents
3
Period of Report
2018-08-02
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cti-item4018xk_a.htm 8-K 36884
2 EXHIBIT 1 a103373lettertosecuri07c.htm EX-1 1482
3 a103373lettertosecuri07c001.jpg GRAPHIC 76912
  Complete submission text file 0000891293-18-000080.txt   145619
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28386 | Film No.: 18989827
SIC: 2834 Pharmaceutical Preparations